 |
|
Association between serum osteoprotegerin level and renal prognosis in nondialysis patients with chronic kidney disease in the Korean Cohort Study for Outcomes in Patients with Chronic Kidney Disease (the KNOW-CKD Study)
Tae Ryom Oh, Chana Myeong, Su Hyun Song, Hong Sang Choi, Sang Heon Suh, Chang Seong Kim, Eun Hui Bae, Wookyung Chung, Kyu Hun Choi, Kook Hwan Oh, Seong Kwon Ma, Soo Wan Kim
Kidney Res Clin Pract. 2022;41(2):200-208. Published online 2021 Dec 29 DOI: https://doi.org/10.23876/j.krcp.21.173
|
|
Citations to this article as recorded by
 Serum Osteoprotegerin Is an Independent Marker of Left Ventricular Hypertrophy, Systolic and Diastolic Dysfunction of the Left Ventricle and the Presence of Pericardial Fluid in Chronic Kidney Disease Patients
Katarzyna Romejko, Aleksandra Rymarz, Katarzyna Szamotulska, Zbigniew Bartoszewicz, Stanisław Niemczyk
Nutrients.2022; 14(14): 2893. CrossRef Elevated Serum Osteoprotegerin is Associated with Reduced Risks of Albuminuria and CKD Progression in Patients with Type 2 Diabetes
Xiaoyang Lou, Zhi Yang, Kexia Wu, Weihong Li, Wan Hu, Ronghui Nie, Ping Tu, Peng Duan
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 3831. CrossRef
|